NexTech Signs AR Deal With Steyr Arms USA
NEW YORK and TORONTO, Feb. 19, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), […]
Arcturus Therapeutics to Present at Two Investor Conferences in March
SAN DIEGO, Feb. 19, 2020 (GLOBE NEWSWIRE) — Arcturus Therapeutics (the “Company”, NASDAQ: ARCT), a leading messenger RNA medicines company […]
Crinetics Pharmaceuticals to Participate in SVB Leerink Global Healthcare Conference
SAN DIEGO, Feb. 19, 2020 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on […]
VIVUS Announces Commercial Launch of Qsymia® in the Republic of Korea Establishing New Royalty Revenue Stream
– VIVUS to Receive Milestone Payment from Alvogen; Significant Worldwide Growth Potential for Qsymia –CAMPBELL, Calif., Feb. 19, 2020 (GLOBE […]
Iterum Therapeutics to Present at the 9th Annual SVB Leerink Global Healthcare Conference
DUBLIN, Ireland and CHICAGO, Feb. 19, 2020 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company focused […]
Calithera to Participate in the 9th Annual SVB Leerink Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Feb. 19, 2020 (GLOBE NEWSWIRE) — Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company […]
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2019 Financial Results
BERKELEY HEIGHTS, N.J., Feb. 19, 2020 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), […]
Iovance Biotherapeutics to Host Fourth Quarter and Full Year 2019 Financial Results Conference Call and Webcast on Tuesday, February 25, 2020
SAN CARLOS, Calif., Feb. 19, 2020 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel […]
Optinose Appoints Victor Clavelli as Chief Commercial Officer
YARDLEY, Pa., Feb. 19, 2020 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose […]
Axsome Therapeutics to Present at Upcoming Investor Conferences
NEW YORK, Feb. 19, 2020 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies […]
